MedPath

Oxford University Clinical Research Unit, Vietnam

🇻🇳Vietnam
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

36

Active:0
Completed:31

Trial Phases

5 Phases

Phase 1:2
Phase 2:7
Phase 3:3
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (28 trials with phase data)• Click on a phase to view related trials

Not Applicable
8 (28.6%)
Phase 4
8 (28.6%)
Phase 2
7 (25.0%)
Phase 3
3 (10.7%)
Phase 1
2 (7.1%)

Adaptive Dengue Antiviral Platform Trial

Phase 2
Not yet recruiting
Conditions
Dengue
Antiviral Drugs
Interventions
Drug: VIS513 (a monoclonal antibody)
Drug: Molnupiravir 400 mg
First Posted Date
2024-08-13
Last Posted Date
2024-08-13
Lead Sponsor
Oxford University Clinical Research Unit, Vietnam
Target Recruit Count
500
Registration Number
NCT06551844
Locations
🇻🇳

Hospital for Tropical Diseases at Ho Chi Minh city, Ho Chi Minh City, Vietnam

Real-time Artificial Intelligent (AI)-Assisted Muscle Ultrasound for Monitoring Muscle Mass Reduction in ICU Patients

Not Applicable
Completed
Conditions
Tetanus
First Posted Date
2023-09-13
Last Posted Date
2024-03-20
Lead Sponsor
Oxford University Clinical Research Unit, Vietnam
Target Recruit Count
254
Registration Number
NCT06034093
Locations
🇻🇳

Hospital for Tropical Diseases at Ho Chi Minh city, Ho Chi Minh City, Vietnam

Management of Sepsis in Resource Limited Settings Using a Delphi Method.

Completed
Conditions
Sepsis
First Posted Date
2023-06-18
Last Posted Date
2024-01-19
Lead Sponsor
Oxford University Clinical Research Unit, Vietnam
Target Recruit Count
36
Registration Number
NCT05909384
Locations
🇻🇳

Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam

Anakinra in Dengue With Hyperinflammation ( AnaDen )

Phase 2
Recruiting
Conditions
Hyperinflammatory Syndrome
Macrophage Activation Syndrome
Severe Dengue
Anti-inflammatory Agents
Dengue
Dengue With Warning Signs
Anakinra
Immuno-modulation
Cytokine Storm
Interventions
Drug: Placebo
First Posted Date
2022-11-10
Last Posted Date
2024-11-22
Lead Sponsor
Oxford University Clinical Research Unit, Vietnam
Target Recruit Count
160
Registration Number
NCT05611710
Locations
🇻🇳

Hospital for Tropical Diseases, Ho Chi Minh, Vietnam

Awake Prone Positioning in Moderate to Severe COVID-19

Not Applicable
Completed
Conditions
Respiratory Distress Syndrome, Adult
Acute Hypoxemic Respiratory Failure
SARS-CoV2 Infection
COVID-19
COVID-19 Acute Respiratory Distress Syndrome
First Posted Date
2021-10-19
Last Posted Date
2023-06-07
Lead Sponsor
Oxford University Clinical Research Unit, Vietnam
Target Recruit Count
93
Registration Number
NCT05083130
Locations
🇻🇳

Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.